Dow Up0.36% Nasdaq Up0.12%

NuVasive, Inc. (NUVA)

-NasdaqGS
35.69 Down 0.23(0.64%) Aug 21, 4:00PM EDT
|After Hours : 35.68 Down 0.01 (0.02%) Aug 21, 4:56PM EDT
ProfileGet Profile for:
NuVasive, Inc.
7475 Lusk Boulevard
San Diego, CA 92121
United States - Map
Phone: 858-909-1800
Fax: 800-475-9134
Website: http://www.nuvasive.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Medical Appliances & Equipment
Full Time Employees:1,358

Business Summary 

NuVasive, Inc., a medical device company, develops and markets minimally disruptive surgical products and procedurally integrated solutions for the spine. Its products focus on applications for spine fusion surgery. The company’s principal product offering includes a minimally disruptive surgical platform, known Maximum Access Surgery (MAS) that includes its proprietary software-driven nerve detection and avoidance systems, NVM5 and NVJJB, and intra-operative monitoring (IOM) support; MaXcess, an integrated split-blade retractor system; and various specialized implants. Its spine surgery product line offerings comprise products for the thoracolumbar and the cervical spine, which are primarily used to enable access to the spine and to perform restorative and fusion procedures in a minimally disruptive fashion. The company’s biologic product line offerings used to aid the spinal fusion process or bone healing consist of allograft (donated human tissue); Osteocel Plus, an allograft cellular matrix containing viable mesenchymal stem cells; FormaGraft, a collagen synthetic product; and AttraX, a synthetic bone graft material. It also provides IOM services for insight into the nervous system during spine and other surgeries. In addition, the company is developing proprietary total disc replacement devices, which include XL-TDR, a mechanical total disc replacement for lateral lumbar spine applications; and the PCM device for cervical spine applications. It sells its products through independent sales agencies, directly-employed sales shareowners, and distributors to surgeons and hospitals in the United States and internationally. NuVasive, Inc. was founded in 1997 and is headquartered in San Diego, California.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on NuVasive, Inc.

Corporate Governance 
NuVasive, Inc.’s ISS Governance QuickScore as of Aug 1, 2014 is 5. The pillar scores are Audit: 1; Board: 2; Shareholder Rights: 5; Compensation: 8.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Mr. Alexis V. Lukianov , 58
Chairman and Chief Exec. Officer
2.03M0.00
Mr. Keith C. Valentine , 46
Pres and Chief Operating Officer
1.10M0.00
Mr. Matthew W. Link , 39
Exec. VP of U.S. Sales
812.00K0.00
Mr. Patrick Miles , 48
Pres of Global Products & Services
1.09M0.00
Mr. Michael J. Lambert , 52
Special Advisor
861.00K0.00
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders